Trial intelligence / Profile preview

Levetiracetam versus sodium valproate monotherapy in children with generalized or focal epilepsy

IRCT20120215009014N351Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial in Focal Onset Epilepsy and epilepsy comparing Levetiracetam monotherapy with Sodium valproate monotherapy (2 arms). Primary endpoint: Number of seizures. Started Jul 2019; status: completed.

02

Drugs

levetiracetamvalproic acid
03

Conditions

Focal Onset Epilepsyepilepsy

Beyond the preview

Go deeper on IRCT20120215009014N351.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120215009014N351.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call